Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Exercise/Conversion of 403 KNSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 403 | n/a |
| Jul 2, 2026 | Kodiak Sciences Inc. (KOD) | Grant/Award | 17,731 | n/a |
| Jun 18, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 454 | n/a |
| Jun 16, 2026 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 31,000 | n/a |
| Jun 2, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,799 | n/a |
| May 22, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 40 | $20.3K |
| Feb 24, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 2,500 | $18.4K |
| Feb 4, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 683 | n/a |
| Jan 26, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 4,000 | $65.8K |
| Nov 14, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 2,500 | $18.4K |